21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Anti-infection P-compound™
#10502ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS
#10503Method to stabilize a dietary supplement to facilitate joint health in humans
#10504Appetite suppressant product and method
#10505COMPOSITION FOR TREATING STERILE INFLAMMATION
#10506Compositions and methods for treating inflammatory arthritis
#10507TREATMENT OF NEUROLOGICAL DISORDERS
#10508SCAVENGER OF IN VIVO HARMFUL REACTIVE OXYGEN SPECIES AND/OR FREE RADICALS
#10509LIP LUBRICANT AND METHOD OF LUBRICATING THE LIPS
#10510Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
#10511Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
#10512ORGANIC COMPOUNDS
#10513ORAL DOSAGE FORM
#10514COMBINATION OF A LONG-ACTING HYPNOTIC AGENT AND A SHORT-ACTING HYPNOTIC AGENT AND THERAPEUTIC USE THEREOF
#10515Opioid agonist/antagonist combinations
#10516Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
#10517ANTIMICROBIAL FORMULATIONS COMPRISING A COMBINATION OF A PYRIDINE THIOL AND A BIS-QUINOLINIUM SALT
#10518Composition for headache treatment
#10519Treatment of Proliferative Disorders Using Antibodies to PSMA
#10520Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation
#10521Diabetic nephropathy therapies
#10522Antibodies that bind to 238P1B2
#10523Method of treating fibrproliferative disorders
#10524Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
#10525Compounds and methods for the treatment of vascular disease
#10526Sealants for Skin and Other Tissues
#10527Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
#10528Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
#10529Inflammatory Disease Treatment
#10530Nutritional compositions for reducing oxidative damage
#10531COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO
#10532Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
#10533INDAZOLE INHIBITORS OF TYROSINE KINASE
#10534METHODS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE AND PATHOGENIC DISEASES
#10535Methods of using ophthalmic compositions comprising povidone-iodine
#10536Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
#10537Dermatologic compositions comprising pyrrolidone-5-carboxylic acid and at least one entity chosen from citrulline, arginine and asparagine, and uses thereof in the treatment of atopic dermatitis
#10538Diagnostic value of systemic ACE pathway activation in the detection by fluorescence of localized pathological lesions
#10539O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
#10540THERAPEUTIC FORMULATIONS FOR THE TREATMENT OF COLD AND FLU-LIKE SYMPTOMS
#10541Compositions and Methods for Ameliorating Clinical Electrical Disturbances
#10542GAS MIST PRESSURE BATH DEVICE
#10543Gas mist pressure bath device
#10544Gas mist pressure bath device
#10545Atherosclerotic Plaque Dissolution Composition
#10546Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications
#10547Medium-chain length fatty acids and glycerides as nephroprotection agents
#10548COMPOSITION COMPRISING A NITROOXYDERIVATIVE OF ACETAMINOPHEN AND A ANTICONVULSANT DRUG FOR THE TREATMENT OF NEUROPATHIC PAIN
#10549MILNACIPRAN FORMULATIONS
#10550Compositions and methods for therapy for diseases characterized by defective chloride transport
#10551COMBINATION THERAPY RELATED TO SEROTONIN DUAL ACTION COMPOUNDS
#10552USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#10553COMBINATION OF METFORMIN AND AN MTP INHIBITOR
#10554Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#10555COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#10556ANTIHELMINTIC PASTE
#10557COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#10558PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B
#10559Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#10560PHARMACEUTICAL COMPOSITION INCLUDING A CORTICOSTEROID AND A VITAMIN D ANALOG HAVING IMPROVED STABILITY
#10561Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
#10562Treatment of Multiple Myeloma
#10563Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
#10564Composition for the treatment of osteoarthritis
#10565Topical ophthalmic compositions containing tobramycin and dexamethasone
#10566Topical methods and compositions for the treatment of eye diseases and conditions
#10567GNRH agonist combination drugs
#10568Method of preventing progression of hypertension-induced heart failure with PKC peptides
#10569Use of VWF stabilized FVIII preparations and of VWF preparations without FVIII for extravascular administration in the therapy and prophylactic treatment of bleeding disorders
#10570USE OF NEUREGULIN-1 IN REDUCING BRAIN DAMAGE
#10571Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders
#10572FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME
#10573Prodrugs of HIV protease inhibitors
#10574USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#10575USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#10576Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly
#10577Ophthalmic Compositions with Hyaluronic Acid
#10578Methods for identifying GLP-1 secretagogues
#10579COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#10580HERBAL COMPOSITION FOR MAINTAINING/CARING THE SKIN AROUND THE EYE, METHODS OF PREPARING THE SAME AND USES THEREOF
#10581Herbal composition for maintaining/caring the skin around the eye, methods of preparing the same and uses thereof
#10582Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
#10583DENTAL STERILIZING WATER, METHOD FOR PRODUCING THE WATER, AND DEVICE FOR PRODUCING THE WATER
#10584Compositions comprising nanoparticles and apoptotic agents and methods of use
#10585PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES
#10586Agent for salting out active principles in dressings containing at least one of fatty substance
#10587TABLETS FOR COMBINATION THERAPY
#10588Combination of triazine derivatives and insulin sensitisers
#10589Novel Antiretroviral Combination
#10590VAGINAL DELIVERY SYSTEM
#10591Methods and compositions for repair of cartilage using an in vivo bioreactor
#10592Methods and compositions for repair of cartilage using an in vivo bioreactor
#10593Methods and compositions for repair of cartilage using an in vivo bioreactor
#10594Methods and compositions for repair of cartilage using an in vivo bioreactor
#10595Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon
#10596Cosmetic treatment system and methods
#10597Micro-RNA family that modulates fibrosis and uses thereof
#10598Immunosuppressive Extract Of Cordyceps Sinensis And Uses Thereof
#10599Use of flagellin in the immunotherapy of
#10600METHOD AND COMPOSITIONS FOR TREATMENT OF CANCERS
#10601Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies
#10602Methods of treating coagulopathy
#10603Leukemic cell CNS infiltration controlled by notch-induced chemotaxis
#10604PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
#10605Methods and compositions for the treatment of cancers and pathogenic infections
#10606Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis
#10607USE OF VEGFR-2 INHIBITORS FOR TREATING METASTATIC CANCER
#10608Use of EDTA and its derivatives for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibiotics exerted in such diseases
#10609COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MIGRAINES
#10610Erythrocyte-encapsulated L-asparaginase for enhanced acute lymphoblastic leukemia therapy
#10611Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
#10612Methods and Compositions for Delivery of Medicaments to the Lungs
#10613Use of PS20/WFDC1 and Interferons to Diagnose, Monitor and Treat Viral Diseases
#10614BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy
#10615Novel compositions for the treatment of wounds and skin care
#10616Injectable Radio-Opaque Compositions for Tissue Augmentation
#10617Method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials
#10618Method of treating pain caused by inflammation
#10619Method of inhibiting inflammatory pain
#10620Oral composition to reduce cold symptoms and duration of same
#10621Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method
#10622Controlled release local anesthetic for post dental surgery and method of use
#10623COMPOSITIONS COMPRISING AN ANTIHISTAMINE, ANTITUSSIVE AND DECONGESTANT IN EXTENDED RELEASE FORMULATIONS
#10624Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions
#10625RHOKINASE-DEPENDENT INHIBITION ACTIVITY ON PULMONARY ARTERY ENDOTHELIUM DYSFUNCTION, MEDIAL WALL THICKNESS AND VASCULAR OBSTRUCTION OF PULMODIL AND PULMODIL-1
#10626PHARMACEUTICAL COMPOSITIONS COMPRISING CHLOROPHENYL PIPERAZINE DERIVED COMPOUNDS AND USE OF THE COMPOUNDS IN PRODUCING MEDICAMENTS
#10627Combination of selected analgesics and COX-II inhibitors
#10628COMBINATIONS OF JAK INHIBITORS
#10629COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF
#10630PHARMACEUTICAL COMPOSITIONS CONTAINING BENFOTIAMINE AND ONE OR ONE MORE PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF PAIN CONDITIONS OF NEUROPATHIC ORIGIN
#10631Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid
#10632Compositions and methods for treating cancer
#10633USE OF ARTEMISININ AND ITS DERIVATIVES IN CANCER THERAPY
#10634Compositions and methods for treating cancer
#10635Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
#10636Oxytocin and melatonin compositions and associated methods for inducing labor
#10637TOPICAL COMPOSITIONS FOR DELIVERY OF PROTEINS AND PEPTIDES
#10638Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
#10639IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS
#10640Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#10641Preparation for restenosis prevention
#10642PRE-PROCEDURE MEAL REGIMEN
#10643Methods for modulating eicosanoid metabolism
#10644Treating male infertility secondary to sperm oxidative stress
#10645Composition for treating skin lesions
#10646Immune System Modulator Formulation
#10647COMPOSITIONS COMPRISING AN ANTIHISTAMINE, ANTITUSSIVE AND DECONGESTANT IN EXTENDED RELEASE FORMULATIONS
#10648PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS
#10649C70-containing liposome, method for producing the same, and use of the same
#10650PROSTAGLANDIN E2 (PGE2) AS AN ADJUVANT IN MONOCLONAL ANTIBODY GENERATION
#10651Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
#10652Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy
#10653Down-regulation of mortalin by siRNA
#10654Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases
#10655COMBINATIONS COMPRISING GEMCITABINE AND TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF PANCREATIC CANCER
#10656Compositions for inhibiting atherosclerosis
#10657Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly
#10658Nutrition with non-viable and non-digestible oligosaccharide
#10659Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
#10660Method for bone marrow preservation or recovery
#10661Method for treating deficiency in hematopoiesis
#10662Preparation for restenosis prevention
#10663Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling
#10664Wound care system and bactericidal methods and devices
#10665STORAGE-STABLE AQUEOUS COMPOSITION COMPRISING A MAGNESIUM COMPOUND AND L-CARNITINE
#10666Preventive or therapeutic drug for Alzheimer-type dementia
#10667ANTIBACTERIAL FORMULATION COMPRISING A DIALKYL SULPHOSUCCINATE AND A CARBANILIDE ANTIBACTERIAL AGENT
#10668Anti-cancer tocotrienol analogues and associated methods
#10669THERAPY-ENHANCING GLUCAN
#10670TREATMENT OF ONYCHOMYCOSIS AND RELATED COMPOSITIONS INCLUDING UREA
#10671Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal
#10672METHOD OF TREATING COGNITIVE IMPAIRMENTS AND SCHIZOPHRENIAS
#10673SULPHIDE BRIDGED DERIVATIVES AS MODULATORS OF MGLUR5 733
#10674INHIBITION OF ALPHA-SYNUCLEIN TOXICITY
#10675ADJUNCTIVE FORMULATION AND METHODS FOR PALLIATION OF FINE WRINKLES, MOTTLED HYPERPIGMENTATION, TACTILE ROUGHNESS OF FACIAL SKIN AND RELATED DISORDERS
#10676MEQUITAZINE FOR TREATING OR PREVENTING PATHOLOGIES INVOLVING HISTAMINE H4 RECEPTORS
#10677SEROTONIN RECEPTOR ANTAGONISTS FOR TREATING ARTHRITIS
#10678ANTIMICROBIAL THERAPY
#10679Soluble, highly branched glucose polymers for enteral and parenteral nutrition and for peritoneal dialysis
#10680HIV Treatment
#10681COMBINATION METHODS OF TREATING CANCER
#10682Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
#10683Compositions comprising compounds of natural origin for damaged skin
#10684Composition Comprising Desmopressin
#10685Co-Therapy For Diabetic Conditions
#10686USE OF SALUSIN BETA ALONE OR IN COMBINATION WITH OCTREOTIDE AS A THERAPEUTIC AGENT
#10687USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#10688Topical compositions for anti-aging and methods of using same
#10689Topical compositions for anti-aging and methods of using same
#10690COMPOSITIONS AND METHODS FOR PREVENTING AND MONITORING DISEASE
#10691MICROCAPSULES COMPRISING LIVER CELLS AND ERYTHROPOIETIN, METHODS FOR PREPARING SAID MICROCAPSULES AND METHODS FOR TREATING A PATIENT COMPRISING APPLYING SAID MICROCAPSULES TO THE PATIENT
#10692COMPOSITIONS COMPRISING STRONTIUM AND USES THEREOF IN THE TREATMENT OR PREVENTION OF GINGIVITIS, PERIODONTITIS, PERIODONTITIS AS A MANIFESTATION OF SYSTEMIC DISEASES, AND NECROTIZING PERIODONTAL DISEASES
#10693Pharmaceutical compositions of amlodipine and valsartan
#10694Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid
#10695Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
#10696Microencapsulated compositions and methods for tissue mineralization
#10697COMBINATION ANTIBIOTIC AND ANTIBODY THERAPY FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION
#10698EMP2 antibodies and their therapeutic uses
#10699Method for treating a disease characterized by reduced appetite
#10700COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#10701COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
#10702METHOD FOR THE TREATMENT OF TYPE AND TYPE IV HYPERSENSITIVITY
#10703IRON FORTIFICATION MUTRITIONAL BLEND
#10704Hyperbaric treatment in wound healing
#10705METHOD FOR IMPROVING PHARMACOKINETICS
#10706Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
#10707Co-Therapy For Diabetic Conditions
#10708Method for inducing lymphoid tissue and modulating intestinal homeostasis
#10709Myocardial perfusion imaging method
#10710Anti-CD74 immunoconjugates and methods of use
#10711Relay link HARQ operation
#10712INHALATION PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO] ETHYL]-2(1H)-QUINOLINONE AND A CORTICOSTEROID
#10713Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
#10714Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
#10715Method of improving sweetness qualities of stevia extract
#10716Amino Acid-Containing Composition for Preventing or Remedying Decrease in the Skeletal Muscle of Aged People
#10717PFKFB4 inhibitors and methods of using the same
#10718Treatment of cancers with acquired resistance to kit inhibitors
#10719Combination of a Serotonin Reuptake Inhibitor and Agomelatine
#10720Pharmaceutical Compositions and Methods for CCR5 Antagonists
#10721Methods of and Combination Therapies for Treating or Delaying the Onset of Dyskinesia
#10722PHARMACEUTICAL FORMULATION
#10723COMBINATION TARGETED THERAPY FOR LUNG CANCER
#10724TREATMENT OF AFFECTIVE DISORDERS BY THE COMBINED ACTION OF A NICOTINIC RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE
#10725METHODS AND COMPOSITIONS TO ENHANCE THE EFFICACY OF PHOSPHODIESTERASE INHIBITORS
#10726METHODS AND COMPOSITIONS TO ENHANCE THE EFFICACY OF PHOSPHODIESTERASE INHIBITORS
#10727Synergistic Modulation of Microglial Activation by Nicotine and THC
#10728Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
#10729Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
#10730CORTICOSTEROIDS TO TREAT EPOTHILONE OR EPOTHILONE DERIVATIVE INDUCED DIARRHEA
#10731BETA GLUCANS AND METHODS OF USE THEREOF
#10732Myeloid differentiation inducing agents
#10733Rifamycin derivatives
#10734Chemosensory receptor ligand-based therapies
#10735Method of Attenuating Neurogenic Swelling or Neurogenic Inflammation
#10736TREATMENT OF OSTEOARTHRITIS
#10737TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH A KINASE INHIBITOR
#10738USE OF CYTOCHROME P450-METABOLIZED DRUGS AND GRF MOLECULES IN COMBINATION THERAPY
#10739USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPY
#10740Enterostatin as Therapeutic Agent for Hypoglycemia
#10741METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE
#10742Methods for treating congestive heart failure
#10743COMPOSITION FOR TREATING AIDS AND ASSOCIATED CONDITIONS
#10744Prevention of Acute Kidney Injury
#10745THIENOBENZODIAZEPINE MODULATORS OF D1 RECEPTOR, D2 RECEPTOR, AND/OR 5-HT2 RECEPTOR
#10746Compositions and Methods for Treating Burns
#10747ORAL PARTICULATE ANTITUMOR PREPARATION
#10748NANOPARTICULATE MEGESTROL FORMULATIONS
#10749Pharmaceutical Suspensions and Related Methods
#10750USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS
#10751Controlled release local anesthetic comprising a biologically active non-sulfated glycosaminoglycan matrix
#10752NANOPARTICLES COMPRISING A NON-IONIZABLE POLYMER AND AN ANIONIC CELLULOSIC POLYMER
#10753Agents and Methods to Stimulate Bone Healing
#10754FATTY ACID ALCOHOLS
#10755PHARMACEUTICAL COMPOSITIONS
#10756Macrocyclic lactone combination compositions, vaccines and methods for producing same
#10757Prevention and treatment of ocular side effects with a cyclosporin
#10758TREATMENT OF INSULIN-RESISTANT DISORDERS
#10759METHOD OF TREATING ERYTHROPOIETIN HYPORESPONSIVE ANEMIAS
#10760COMBINATION THERAPY
#10761Antibodies against the ectodomain of ErbB3 and uses thereof
#10762COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTHIONE REDUCTASE
#10763METHOD AND MEANS FOR OBTAINING BRONCHORELAXATION
#10764PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN
#10765USE OF URATE OXIDASE FOR THE TREATMENT OR PROPHYLAXIS OF DISORDERS OR INDIRECT SEQUELAE OF THE HEART CAUSED BY ISCHEMIC OR REPERFUSION EVENTS
#10766Treatments involving glutaredoxins and similar agents
#10767Peptide-based scaffolds for cartilage regeneration and methods for their use
#10768Linked dibenzimidazole antivirals
#10769AG-205 for the treatment of breast cancer
#10770IL-17 binding proteins
#10771Treatment of malodour
#10772PHARMACEUTICAL FOAM
#10773METHODS AND COMPOSITIONS FOR ORGAN PROTECTION
#10774Anti-CD74 immunoconjugates and methods of use
#10775Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal Antibody
#10776Portable powder delivery system and method
#10777Compositions containing sesamin-class compound(s) and arachidonic acid class compound(s)
#10778AGENT FOR REDUCING INTESTINAL TOXIC BACTERIUM AND FOOD OR PHARMACEUTICAL PREPARATION COMPRISING THE SAME
#10779Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
#10780Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
#10781PHARMACEUTICAL COMPOSITION FOR IMPROVING LOWER URINARY TRACT SYMPTOMS
#107825-HTreceptor agonist compounds for treatment of cognitive disorders
#10783STABLE LORATADINE SPILL RESISTANT FORMULATION
#10784PHARMACEUTICAL FORMULATION
#10785PHARMACEUTICAL FORMULATION
#10786Stable methylnaltrexone preparation
#10787Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate
#10788TREATMENT OF AML
#10789N-PYRAZOLE-2-PYRIDINE CARBOXAMIDE DERIVATIVE
#10790Organic compounds
#10791TREATMENT OF ONYCHOMYCOSIS AND RELATED COMPOSITIONS
#10792NOVEL COMBINATIONS
#10793Stabilization of oily suspensions comprising hydrophobic silicas
#10794Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction
#10795Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction
#10796Pharmaceutical compositions of pyrimidine-2,4,6-triones
#10797COMPLEXES OF PHOSPHATE DERIVATIVES
#10798Unit dosage for brain health
#10799Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof
#10800Method for expansion of stem cells